Essa Pharma Stock Price To Book

EPIX Stock  USD 1.68  0.02  1.18%   
ESSA Pharma fundamentals help investors to digest information that contributes to ESSA Pharma's financial success or failures. It also enables traders to predict the movement of ESSA Stock. The fundamental analysis module provides a way to measure ESSA Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ESSA Pharma stock.
Price To Book Ratio is likely to rise to 52.01 in 2025.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ESSA Pharma Company Price To Book Analysis

ESSA Pharma's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

 = 

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current ESSA Pharma Price To Book

    
  0.62 X  
Most of ESSA Pharma's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ESSA Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

ESSA Price To Book Driver Correlations

Understanding the fundamental principles of building solid financial models for ESSA Pharma is extremely important. It helps to project a fair market value of ESSA Stock properly, considering its historical fundamentals such as Price To Book. Since ESSA Pharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ESSA Pharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ESSA Pharma's interrelated accounts and indicators.
1.0-0.89-0.910.32-0.041.0-0.010.970.980.59-0.150.660.990.990.40.96
1.0-0.89-0.910.3-0.091.0-0.020.970.990.58-0.150.640.990.990.410.96
-0.89-0.890.8-0.340.01-0.890.0-0.86-0.89-0.550.13-0.7-0.88-0.88-0.42-0.84
-0.91-0.910.8-0.47-0.05-0.9-0.03-0.97-0.95-0.650.19-0.54-0.88-0.88-0.5-0.95
0.320.3-0.34-0.470.660.320.240.40.350.270.180.480.30.30.340.39
-0.04-0.090.01-0.050.66-0.040.22-0.01-0.070.41-0.050.16-0.08-0.090.04-0.09
1.01.0-0.89-0.90.32-0.04-0.010.970.980.6-0.160.660.990.990.40.96
-0.01-0.020.0-0.030.240.22-0.010.020.00.020.170.02-0.04-0.040.1-0.03
0.970.97-0.86-0.970.4-0.010.970.020.990.62-0.170.570.940.940.530.97
0.980.99-0.89-0.950.35-0.070.980.00.990.59-0.160.60.960.960.510.97
0.590.58-0.55-0.650.270.410.60.020.620.59-0.250.520.570.570.310.55
-0.15-0.150.130.190.18-0.05-0.160.17-0.17-0.16-0.250.17-0.16-0.16-0.09-0.17
0.660.64-0.7-0.540.480.160.660.020.570.60.520.170.670.670.140.58
0.990.99-0.88-0.880.3-0.080.99-0.040.940.960.57-0.160.671.00.340.97
0.990.99-0.88-0.880.3-0.090.99-0.040.940.960.57-0.160.671.00.340.97
0.40.41-0.42-0.50.340.040.40.10.530.510.31-0.090.140.340.340.48
0.960.96-0.84-0.950.39-0.090.96-0.030.970.970.55-0.170.580.970.970.48
Click cells to compare fundamentals
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition

ESSA Book Value Per Share

Book Value Per Share

2.02

At this time, ESSA Pharma's Book Value Per Share is fairly stable compared to the past year.
Based on the latest financial disclosure, ESSA Pharma has a Price To Book of 0.6242 times. This is 97.57% lower than that of the Biotechnology sector and 89.67% lower than that of the Health Care industry. The price to book for all United States stocks is 93.44% higher than that of the company.

ESSA Price To Book Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ESSA Pharma's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ESSA Pharma could also be used in its relative valuation, which is a method of valuing ESSA Pharma by comparing valuation metrics of similar companies.
ESSA Pharma is currently under evaluation in price to book category among its peers.

ESSA Pharma Current Valuation Drivers

We derive many important indicators used in calculating different scores of ESSA Pharma from analyzing ESSA Pharma's financial statements. These drivers represent accounts that assess ESSA Pharma's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of ESSA Pharma's important valuation drivers and their relationship over time.
202020212022202320242025 (projected)
Market Cap28.4M154.9M80.1M136.2M268.3M61.5K
Enterprise Value(21.2M)98.6M23.3M102.6M164.9M60.7K

ESSA Fundamentals

About ESSA Pharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ESSA Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ESSA Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ESSA Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for ESSA Stock Analysis

When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.